SCHEMBL18769332

SCHEMBL18769332

CNCc1c(N)c2cc(O)ccc2n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
ALOX5 P09917 6/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
F2RL3 Q96RI0 1/20 0.39
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SPR P35270 1/20 0.36
ALOX15 P16050 1/20 0.36
WEE1 P30291 1/20 0.35
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17928546 0.74 BCHE (0.46) BCHEACHEALOX5PTGS1PTGS2
SCHEMBL11808516 0.70 BCHE (0.67) BCHEACHEALOX5PTGS1PTGS2
SCHEMBL3874806 0.68 BCHE (0.56) BCHEACHEALOX5PTGS1PTGS2
SCHEMBL5857121 0.66 AS3MT (0.56) BCHEACHEALOX5PTGS1PTGS2
SCHEMBL9095202 0.65 ALOX5 (0.53) ALOX5MEN1KMT2ASPRALOX15
SCHEMBL2403408 0.64 KDM4E (0.49) ALOX5MEN1KMT2AALOX15EGFR
SCHEMBL20384979 0.63 ACHE (0.57) BCHEACHEALOX5PTGS1PTGS2
SCHEMBL27985040 0.63 GPR3 (0.64) BCHEACHEALOX5PTGS1PTGS2
SCHEMBL12926001 0.63 MAPT (0.53) BCHEACHEALOX5PTGS1PTGS2
SCHEMBL1093460 0.62 ACLY (0.47) F2RL3KDM4EALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017066661-A1 Non-Selective Protease Activated Receptor 4 Ala120Thr Isoform Antagonist THOMAS JEFFERSON UNIVERSITY (US) 2017-04-20 WO disclosed